IN VITRO AND IN VIVO INVESTIGATION OF PROBIOTICS ISOLATED FROM HUMAN MILK

People all over the world are embracing probiotics as a result of growing awareness of the health advantages connected to ingesting living bacteria. Proper administration of probiotics has been shown to provide numerous health advantages to the host. The Lactobacillus genus, which naturally resides in the mucosal linings of humans and animals, and it is essential for stabilizing the gastrointestinal tract and protecting intestinal health from infections. There has been a great deal of interest in their potential uses as probiotics, mucosal vaccine vectors, and agents regulating metabolic activities. The present study aimed at isolating and characterizing novel probiotics from human milk and functionally assessing them in vivo for their physiological, enzymatic and antimicrobial activity. Probiotic isolates from human milk were amylolytic, proteolytic and lipolytic and were found to be tolerant to low pH of 3.5, 10% salt and 0.3% bile salt. Primary method of cross streaking and secondary streaking by agar diffusion method revealed antagonistic activity of the isolates against tests pathogens of humans viz., S. aureus Newman, P. fluorescens, S. epidermis and S. aureus. Antibiofilm activity of probiotic isolates in vivo against P. fluorescens and S. aureus Newman indicated that the metabolites present in the Cell Free Supernatant (CFS) of the isolates may have the ability to inhibit the formation of biofilm of pathogenic strains. The most efficient probiotic isolates was identified as Weissella confusa and the NCBI GenBank accession number was obtained. The infected mice administered with probiotic isolate Weissella confusa PS17 showed reduced mortality rate than the mice infected with pathogenic strain S. aureus Newman, thus indicating that probiotic strain boosted the immune response of the mice. The Serum uric acid levels was normalised after the infected mice was treated with W. confusa PS17 and this in turn enhanced the survival rate of mice. The present study indicates that isolate W. confusa PS17 can be a promising candidate in improving the condition of health.

Authors

Institutions

Publication Details

Journal
Journal of Microbiology Biotechnology and Food Sciences
Published
2024-09-16
DOI
https://doi.org/10.55251/jmbfs.9587
Primary Topic
Infant Nutrition and Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IN VITRO AND IN VIVO INVESTIGATION OF PROBIOTICS ISOLATED FROM HUMAN MILK

Manikandan Kathirvel, Saranya Panneerselvam, Kabilan G Mariappan, Sangeetha Menon
Journal of Microbiology Biotechnology and Food Sciences
Infant Nutrition and Health
article

IN VITRO AND IN VIVO INVESTIGATION OF PROBIOTICS ISOLATED FROM HUMAN MILK

Manikandan Kathirvel, Saranya Panneerselvam, Kabilan G Mariappan, Sangeetha Menon
article en

Abstract

People all over the world are embracing probiotics as a result of growing awareness of the health advantages connected to ingesting living bacteria. Proper administration of probiotics has been shown to provide numerous health advantages to the host. The Lactobacillus genus, which naturally resides in the mucosal linings of humans and animals, and it is essential for stabilizing the gastrointestinal tract and protecting intestinal health from infections. There has been a great deal of interest in their potential uses as probiotics, mucosal vaccine vectors, and agents regulating metabolic activities. The present study aimed at isolating and characterizing novel probiotics from human milk and functionally assessing them in vivo for their physiological, enzymatic and antimicrobial activity. Probiotic isolates from human milk were amylolytic, proteolytic and lipolytic and were found to be tolerant to low pH of 3.5, 10% salt and 0.3% bile salt. Primary method of cross streaking and secondary streaking by agar diffusion method revealed antagonistic activity of the isolates against tests pathogens of humans viz., S. aureus Newman, P. fluorescens, S. epidermis and S. aureus. Antibiofilm activity of probiotic isolates in vivo against P. fluorescens and S. aureus Newman indicated that the metabolites present in the Cell Free Supernatant (CFS) of the isolates may have the ability to inhibit the formation of biofilm of pathogenic strains. The most efficient probiotic isolates was identified as Weissella confusa and the NCBI GenBank accession number was obtained. The infected mice administered with probiotic isolate Weissella confusa PS17 showed reduced mortality rate than the mice infected with pathogenic strain S. aureus Newman, thus indicating that probiotic strain boosted the immune response of the mice. The Serum uric acid levels was normalised after the infected mice was treated with W. confusa PS17 and this in turn enhanced the survival rate of mice. The present study indicates that isolate W. confusa PS17 can be a promising candidate in improving the condition of health.

Journal of Microbiology Biotechnology and Food SciencesVol. 14(2)
Institute of Life Sciences (IN)
Department of Biotechnology, Ministry of Science and Technology, India
Openalex Percentile: Top 78%
Infant Nutrition and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.